- Tytuł :
- Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)
- Autorzy :
- Źródło :
- In Annals of Oncology April 2020 31(4):495-500
-
Czasopismo naukowe